
Advertise on podcast: NeuroFrontiers
This podcast has
186 episodes
Language
EnglishPublisher
ReachMDExplicit
No
Date created
2015/04/01
Latest episode
2026/08/31
Average duration
10 min.
Release period
17 days
Description
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health. So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
Unlock NeuroFrontiers podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check NeuroFrontiers social media presence
Podcast episodes
Check latest episodes from NeuroFrontiers podcast
Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
2026/08/31
No Label: Geoff Kerchner, MD, PhD
Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease.
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
2026/08/20
No Label: Michael Irizarry, MD, MPH
Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Eisai, Nutley, NJ, discusses the evidence supporting subcutaneous lecanemab for early Alzheimer disease, including dosing, amyloid clearance, and safety monitoring.
Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
2026/07/17
No Label: Luka Kulic, MD
In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses the investigational Brainshuttle technology, including results from the BrainShuttle AD clinical trials as a treatment for early Alzheimer disease along with the broader implications of enhanced blood-brain barrier drug delivery in neurology.
Multidisciplinary Coordination in TK2d Diagnosis and Management
2026/06/24
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Guest: Oscar H. (Hank) Mayer, MD
Thymidine kinase 2 deficiency (TK2d) is a rare mitochondrial myopathy that can involve multiple organ systems, requiring care from different specialties. Given that need for multidisciplinary coordination, Dr. Charles Turck speaks with Drs. Hank Mayer and Zuela Zolkipli-Cunningham to learn how we can improve communication and collaboration across the care team throughout the diagnostic and management journey. Coming to us from the Children's Hospital of Philadelphia, Dr. Mayer is the Director of the Pulmonary Function Laboratory, and Dr. Zolkipli-Cunningham is the Director of Clinical Research in the Mitochondrial Medicine Frontier Program.
Advancing MOGAD Care: Insights from the METEOROID Trial
2026/06/24
No Label: Michael Levy, MD, PhD
No Label: Peter V. Sguigna, MD
What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Levy, MD, Massachusetts General Hospital, Boston, MA, discusses relapse prevention, diagnostic challenges, and the future of MOGAD management with Peter Sguigna, MD, UT Southwestern Medical Center, Dallas, TX.
Navigating Stem Cell Therapy Conversations in MS
2026/06/08
Guest: Jaime Imitola, MD
As stem cell therapies continue to generate significant interest among patients with multiple sclerosis (MS), clinicians must be prepared to distinguish between approved treatments, investigational approaches, and unproven interventions marketed through stem cell tourism. Hear more as Dr. Jaime Imitola discusses the current landscape of stem cell therapies in MS, the risks associated with unregulated treatments, and the importance of patient education and evidence-based guidance. Dr. Imitola is the Vice Chair for Research of the Department of Neurology and the Director of the Division of Multiple Sclerosis and Translational Neuroimmunology at UConn Health. He also spoke about this topic at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting.
Cognitive Screening in MS: Practical Strategies and Modern Approaches
2026/05/28
Guest: Elizabeth S. Gromisch, PhD
Cognitive changes are a common but complex aspect of multiple sclerosis care, making practical and accessible screening strategies essential. In this program, Dr. Elizabeth Gromisch explores both traditional and digital cognitive screening tools for MS and shares real-world insights on selecting and implementing assessments across a range of clinical settings. Dr. Gromisch is a research neuropsychologist at the Joyce D. and Andrew J. Mandell Center for Comprehensive Multiple Sclerosis Care and Neuroscience Research at Mount Sinai Rehabilitation Hospital, Trinity Health of New England. She also discussed this topic at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting.
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
2026/05/14
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Bethany Lussier, MD
Patients often present with respiratory symptoms that don’t quite align with typical pulmonary findings. So what clues should raise our suspicion that something beyond primary lung disease might be driving their condition? Joining Dr. Charles Turck to talk about the pulmonologist’s role in identifying respiratory manifestations of thymidine kinase 2 deficiency (TK2d) is Dr. Bethany Lussier. She shares the hallmark features to look out for, like orthopnea and hypoventilation, as well as best practices for using pulmonary function testing and inspiratory pressure measures to distinguish muscle weakness from primary lung disease. Dr. Lussier is an Associate Professor of Internal Medicine at UT Southwestern Medical Center in Dallas, where she's also a member of the Division of Pulmonary and Critical Care Medicine.
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
2026/05/14
Host: Alexandria May, PharmD, BCPS
Guest: Kaitlin Batley, MD
Fatigue and muscle weakness may seem routine, but when do they signal an underlying condition like thymidine kinase 2 deficiency (TK2d)? To find out, Dr. Alexandria May speaks with Dr. Kaitlin Batley, Director of the Pediatric Neuromuscular Program at Children’s Health and an Assistant Professor of Pediatrics and Neurology at UT Southwestern Medical Center. They discuss how multisystem involvement can help distinguish TK2d from more common neuromuscular disorders and how we can achieve diagnostic clarity through advanced genetic testing, metabolic evaluation, and muscle biopsy.
Understanding Variability in Myasthenia Gravis
2026/05/01
Guest: Henry Kaminski, MD
Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment decisions. Dr. Kaminski is the Meta A. Neumann Professor of the Department of Neurology at The George Washington University School of Medicine and Health Sciences in Washington.
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
2026/03/30
Guest: Aaron Miller, MD
Early real-world experience with the 2024 McDonald criteria suggests a meaningful increase in multiple sclerosis (MS) diagnoses, driven largely by recognition of optic nerve involvement and reclassification of radiologically isolated syndrome. Hear from Dr. Aaron Miller as he reviews emerging evidence, explains how these updates are reshaping diagnostic pathways, and addresses practical challenges in implementation. Dr. Miller is the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis and a Professor of Neurology at the Icahn School of Medicine at Mount Sinai in New York. He also spoke about this topic at the 2026 American Academy of Neurology (AAN) Annual Meeting.
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
2026/02/19
Guest: Raphael Schneider, MD, PhD, FRCPC, CIP
Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple sclerosis (MS) by capturing interconnected pathways in a single sample. Hear from Dr. Raphael Schneider as he explores how these tools could inform prognosis, risk stratification, and clinical trial design, which he spoke about at the 2026 ACTRIMS Forum. Dr. Schneider is a neurologist and researcher at the BARLO MS Centre at St. Michael’s Hospital as well as an Assistant Professor and the Elizabeth S. Barford Early Career Professor in Multiple Sclerosis in the Department of Medicine at the University of Toronto.
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
2026/02/19
Guest: Adil Harroud, MD
Guest: Dylan Hamitouche
Host: Ryan Quigley
Multimodal aging signatures are reshaping our understanding of progression and prognosis in multiple sclerosis (MS). Host Ryan Quigley sits down with Dr. Adil Harroud and Mr. Dylan Hamitouche to learn more about implications for the future of risk stratification and personalized treatment in MS, a topic they presented on at the 2026 ACTRIMS Forum. Dr. Harroud is a neurologist and the co-leader of the Neuroimmunology Diseases Research Group at the Montreal Neurological Institute at McGill University. Mr. Hamitouche is a medical student at McGill University.
Understanding Accelerated Biological Aging in Pediatric MS
2026/02/19
Guest: Jennifer Yang, MD
Emerging evidence shows that children with multiple sclerosis exhibit accelerated biological aging. Learn more about the potential implications with Dr. Jennifer Yang, who spoke about this topic at the 2026 ACTRIMS Forum. She's an Assistant Professor of Neurosciences at the UC San Diego School of Medicine and the Division of Pediatric Neurology at Rady Children's Hospital.
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
2026/01/16
Host: Jerome Lisk, MD, MBA, M.S., FAAN
Guest: Michael Salvatore, PhD
Guest: Vicki Nejtek-Salvatore, PhD
Translational research is reshaping the way we understand, detect, and manage Parkinson’s disease. To learn more about how current research efforts are uncovering early biomarkers and redefining intervention strategies, Dr. Jerome Lisk sits down with Dr. Michael Salvatore and Dr. Vicki Nejtek-Salvatore, professors at University of North Texas Health Science Center in Fort Worth and co-founders of the Parkinson Discovery Institute in Fort Worth, Texas.
Podcast reviews
Read NeuroFrontiers podcast reviews
Podcast sponsorship advertising
Start advertising on NeuroFrontiers relevant audience podcasts
You may also like to advertise on these Podcasts

4.8104532000
Steve Deace Show
Blaze Podcast Network

4.824781898
Deck The Hallmark
Bramble Jam Podcast Network

4.838332000
Entrepreneurs on Fire
John Lee Dumas of EOFire

4.98691800
The Adam Mockler Show
MeidasTouch Network

4.858251935
Sara Gonzales Unfiltered
Blaze Podcast Network

4.7368481299
Louder with Crowder
Louder with Crowder

4.723181987
Timeless Wisdom with Dennis Prager
Salem Podcast Network

4.6221782000
Mark Levin Podcast
Cumulus Podcast Network

4.922441853
The Ten Minute Bible Hour Podcast
Matt Whitman

4.82494972
The 1000 Hours Outside Podcast
1000 Hours Outside

